Free Trial

Insider Selling: CorVel Co. (NASDAQ:CRVL) Director Sells 150 Shares of Stock

CorVel logo with Business Services background

CorVel Co. (NASDAQ:CRVL - Get Free Report) Director R Judd Jessup sold 150 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $111.76, for a total value of $16,764.00. Following the completion of the sale, the director now owns 128,682 shares in the company, valued at approximately $14,381,500.32. This represents a 0.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

R Judd Jessup also recently made the following trade(s):

  • On Thursday, May 29th, R Judd Jessup sold 687 shares of CorVel stock. The shares were sold at an average price of $111.25, for a total value of $76,428.75.
  • On Tuesday, May 27th, R Judd Jessup sold 935 shares of CorVel stock. The shares were sold at an average price of $113.50, for a total value of $106,122.50.

CorVel Price Performance

Shares of CRVL remained flat at $109.56 during trading hours on Friday. 81,991 shares of the company traded hands, compared to its average volume of 119,905. The business's fifty day moving average is $112.15 and its 200-day moving average is $116.31. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61. The firm has a market cap of $5.63 billion, a price-to-earnings ratio of 64.45 and a beta of 1.02.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Thursday, May 22nd. The business services provider reported $0.51 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%. The firm had revenue of $231.51 million during the quarter.

Hedge Funds Weigh In On CorVel

Several large investors have recently made changes to their positions in CRVL. Barclays PLC lifted its stake in shares of CorVel by 380.8% in the 3rd quarter. Barclays PLC now owns 15,977 shares of the business services provider's stock valued at $5,223,000 after purchasing an additional 12,654 shares during the period. SG Americas Securities LLC lifted its stake in shares of CorVel by 322.2% in the 4th quarter. SG Americas Securities LLC now owns 1,520 shares of the business services provider's stock valued at $169,000 after purchasing an additional 1,160 shares during the period. Exchange Traded Concepts LLC lifted its stake in shares of CorVel by 216.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 532 shares of the business services provider's stock valued at $59,000 after purchasing an additional 364 shares during the period. Fifth Third Bancorp lifted its stake in shares of CorVel by 45.9% in the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock valued at $36,000 after purchasing an additional 101 shares during the period. Finally, KBC Group NV lifted its stake in shares of CorVel by 304.9% in the 4th quarter. KBC Group NV now owns 1,158 shares of the business services provider's stock valued at $129,000 after purchasing an additional 872 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.

Check Out Our Latest Analysis on CRVL

About CorVel

(Get Free Report)

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.

Featured Articles

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Should You Invest $1,000 in CorVel Right Now?

Before you consider CorVel, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.

While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines